Last checked at 4 May 2020 10:41
04 May 20
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
GlaxoSmithKline Capital plc
Pre-stabilisation Period Announcement
J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).
The securities: | |
Issuer: | GlaxoSmithKline Capital plc |
Guarantor (if any): | N/A |
Aggregate nominal amount: | Long 8yr - GBP bmk 15yr - GBP bmk 3yr - EUR bmk |
Description: | GBP Long 8Y FXD Senior Unsecured Notes GBP 15Y FXD Senior Unsecured Notes EUR 3yr FXD Senior Unsecured Notes Listing: London Stock Exchange |
Offer price: | TBC |
Other offer terms: | Denoms: GBP 100,000 x GBP 1,000 EUR 100,000 x EUR 1,000 |
Stabilisation: | |
Stabilisation Manager(s): | J.P. Morgan Cazenove (Stabilisation coordinator) Barclays (Stabilisation Manager(s)) GSI (Stabilisation Manager(s)) HSBC (Stabilisation Manager(s))
|
Stabilisation period expected to start on: | 04 May 20 |
Stabilisation period expected to end no later than: | 04 Jun 20 |
Existence, maximum size and conditions of use of over‑allotment facility: | The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above. |
Stabilisation trading venue: | Over the counter, TBC |
In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.
In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State
This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.